Back to search
Healthy Volunteers (Diabetes Mellitus, Type 2)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Healthy Volunteers (Diabetes Mellitus, Type 2) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Healthy Volunteers (Diabetes Mellitus, Type 2) trials you may qualify forThe purpose of this study is to assess the pharmacokinetics (PK), safety and tolerability of different oral formulations of AZD5004, and to evaluate the effect…
This study will evaluate safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of single ascending doses (SAD) and multiple ascending doses (MA…
The purpose of this study is to: * evaluate the safety and tolerability of single ascending doses of ALN-4324 in healthy volunteers and to characterize the sin…
The main purpose of this study is to evaluate the safety, tolerability of LY4086940 and how it is processed in the body. Participation in Part A of the study w…
This is a randomized, open, single-dose, crossover-design, phase I study to evaluate the pharmacokinetics and safety after co-administration of L03RD1 and L03RD…
This study is to evaluate the food effect (FE) on the PK of 200 mg CX11 in healthy participants
This study is testing a new medicine that might help treat people with type 2 diabetes. The purpose of the study is to see if the new study medicine is safe and…
This clinical trial is a randomized, open-label, single oral dose, two-sequence, and two-period crossover study to evaluate the pharmacokinetics and safety betw…